|
16 Companies |
|
19 Products |
|
19 Products |
|
0 Mechanisms of Action |
|
1 Trial |
|
60 News |
|
| 12» |
- | Trial completion date, Trial termination: Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer (clinicaltrials.gov) - Aug 16, 2018
P=N/A, N=1000, Terminated, Sponsor: Vanderbilt-Ingram Cancer Center
Trial completion date: Dec 2020 --> Feb 2018 | Active, not recruiting --> Terminated; Low accrual
- | Trial completion: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 1, 2018
P2, N=100, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Trial completion date: Dec 2020 --> Feb 2018 | Active, not recruiting --> Terminated; Low accrual Recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors (clinicaltrials.gov) - Apr 30, 2018
P=N/A, N=59, Completed, Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Apr 2018 | Trial primary completion date: Jun 2019 --> Apr 2018
- | Trial completion date, Trial primary completion date: A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors (clinicaltrials.gov) - Apr 18, 2018
P=N/A, N=60, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Apr 2018 | Trial primary completion date: Jun 2019 --> Apr 2018 Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Jun 2018 --> Jun 2019
- | Trial completion, Trial primary completion date, Metastases: Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors (clinicaltrials.gov) - May 8, 2017
P2, N=64, Completed, Sponsor: Gynecologic Oncology Group
Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Jun 2018 --> Jun 2019 Recruiting --> Completed | Trial primary completion date: Jun 2010 --> Jun 2015
- | Trial primary completion date: A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors (clinicaltrials.gov) - May 2, 2017
P=N/A, N=60, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting --> Completed | Trial primary completion date: Jun 2010 --> Jun 2015 Trial primary completion date: Jun 2017 --> Jun 2018
- | Trial primary completion date: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Apr 13, 2017
P2, N=100, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Trial primary completion date: Jun 2017 --> Jun 2018 Trial primary completion date: Aug 2016 --> Aug 2018
- | Enrollment closed, Trial primary completion date: Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=1000, Active, not recruiting, Sponsor: Vanderbilt University Medical Center
Trial primary completion date: Aug 2016 --> Aug 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Dec 2014
- Trial completion: Collecting Tumor Samples From Patients With Gynecological Tumors (clinicaltrials.gov) - Oct 28, 2016
P=N/A, N=275, Completed, Sponsor: Gynecologic Oncology Group
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Dec 2014 Recruiting --> Completed
- New trial: French GTDC: The French National Reference Centre of GTD (clinicaltrials.gov) - Sep 8, 2016
P=N/A, N=25500, Recruiting, Sponsor: Hospices Civils de Lyon
- Trial primary completion date: A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors (clinicaltrials.gov) - May 3, 2016
P=N/A, N=60, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting --> Completed Trial primary completion date: Jun 2016 --> Jun 2017
- | dactinomycin / Generic mfg.
Trial completion: Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia (clinicaltrials.gov) - Feb 8, 2016
P3, N=240, Completed, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Jun 2016 --> Jun 2017 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Oct 9, 2015
P=N/A, N=39, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2012
- Enrollment open, Enrollment change, Trial primary completion date: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Aug 11, 2015
P2, N=100, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2012 Active, not recruiting --> Recruiting | N=60 --> 100 | Trial primary completion date: Sep 2015 --> Aug 2016
- Trial primary completion date, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=48, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Recruiting | N=60 --> 100 | Trial primary completion date: Sep 2015 --> Aug 2016 Trial primary completion date: Sep 2014 --> Jul 2015
- Trial primary completion date: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 11, 2015
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Trial primary completion date: Sep 2014 --> Jul 2015 Trial primary completion date: Sep 2013 --> Sep 2015
- Trial primary completion date: A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors (clinicaltrials.gov) - Apr 30, 2015
P=N/A, N=60, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Trial primary completion date: Sep 2013 --> Sep 2015 Trial primary completion date: Jun 2015 --> Jun 2016
- | Trial completion: Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation (clinicaltrials.gov) - Apr 28, 2015
P=N/A, N=0, Completed, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Completed
- |||| dactinomycin / Generic mfg.
Trial primary completion date: Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia (clinicaltrials.gov) - Jan 2, 2015
P3, N=240, Completed, Sponsor: Gynecologic Oncology Group
Recruiting --> Completed Trial primary completion date: May 2007 --> Jul 2010
- | Trial completion: Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (clinicaltrials.gov) - Sep 8, 2014
P1, N=0, Completed, Sponsor: Indiana University School of Medicine
Trial primary completion date: May 2007 --> Jul 2010 No longer recruiting --> Completed
- | Trial completion, Enrollment change: Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors (clinicaltrials.gov) - Jul 24, 2014
P1, N=16, Completed, Sponsor: Children's Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed | N=24 --> 16
- Enrollment closed, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - May 19, 2014
P=N/A, N=48, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed | N=24 --> 16 Recruiting --> Active, not recruiting
- | Trial completion: Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation (clinicaltrials.gov) - May 4, 2014
P=N/A, N=0, Completed, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial withdrawal: Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant (clinicaltrials.gov) - Mar 5, 2014
P=N/A, N=0, Withdrawn, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Active, not recruiting --> Withdrawn
- Enrollment change: Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant (clinicaltrials.gov) - Mar 5, 2014
P=N/A, N=0, Withdrawn, Sponsor: Mayo Clinic
Active, not recruiting --> Withdrawn N=46 --> 0
- | Campath (alemtuzumab) / Sanofi
Trial completion, Combination therapy: Campath-1H + FK506 and Methylprednisolone for GVHD (clinicaltrials.gov) - Feb 22, 2014
P2, N=34, Completed, Sponsor: Case Comprehensive Cancer Center
N=46 --> 0 Active, not recruiting --> Completed
- | Trial completion: Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | amifostine / Generic mfg.
Trial completion: Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=100, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | valacyclovir / Generic mfg.
Trial completion: Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation (clinicaltrials.gov) - Feb 22, 2014
P3, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Synagis (palivizumab) / AbbVie, AstraZeneca, SOBI
Trial completion: Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | amphotericin b liposome / Generic mfg.
Trial completion: Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | captopril / Generic mfg.
Trial completion: Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation (clinicaltrials.gov) - Feb 19, 2014
P3, N=35, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, Neumega (oprelvekin) / Astellas
Trial completion: Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | fluconazole oral / Generic mfg., itraconazole / Generic mfg.
Trial completion: Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation (clinicaltrials.gov) - Feb 19, 2014
P3, N=578, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | dactinomycin / Generic mfg.
Trial completion: Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion, Metastases: Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity (clinicaltrials.gov) - Feb 19, 2014
P1, N=20, Completed, Sponsor: New York University School of Medicine
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation (clinicaltrials.gov) - Feb 19, 2014
P2, N=30, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jul 25, 2013
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy (clinicaltrials.gov) - Jun 9, 2013
P1, N=20, Completed, Sponsor: University of Louisville
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial termination: Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant (clinicaltrials.gov) - May 10, 2013
P1, N=252, Terminated, Sponsor: Vanderbilt-Ingram Cancer Center
Recruiting --> Completed Completed --> Terminated; study closed prematurely upon PI's departure from VICC
- pemetrexed / Generic mfg.
Trial termination: Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy (clinicaltrials.gov) - Apr 9, 2013
P2, N=55, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated; study closed prematurely upon PI's departure from VICC Completed --> Terminated
- Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap, Leukine (sargramostim) / Partner Therap
Trial completion: Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (clinicaltrials.gov) - Mar 20, 2013
P2, N=40, Completed, Sponsor: Cancer Treatment Centers of America
Completed --> Terminated Active, not recruiting --> Completed
- Trial termination: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (clinicaltrials.gov) - Mar 13, 2013
P3, N=240, Terminated, Sponsor: OHSU Knight Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Terminated
- cefepime hydrochloride / Generic mfg.
Trial completion: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (clinicaltrials.gov) - Feb 26, 2013
P1, N=70, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
Active, not recruiting --> Terminated Active, not recruiting --> Completed
- HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Jan 8, 2013
P=N/A, N=48, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
- | New P2 trial: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jan 8, 2013
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
- Trial completion: Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (clinicaltrials.gov) - Nov 3, 2012
P=N/A, N=190, Completed, Sponsor: Vanderbilt-Ingram Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant (clinicaltrials.gov) - Oct 15, 2012
P=N/A, N=115, Completed, Sponsor: Masonic Cancer Center, University of Minnesota
Active, not recruiting --> Completed N=90 --> 115